Search results
Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy
Pharmaceutical Technology· 6 days agoOhtuvayre is expected to generate global sales of $1.1bn by 2029, per a GlobalData analysis. The...
2seventy slims down with sale of hemophilia assets to Novo
BioPharma Dive· 6 days agoFive months later, 2seventy sold off much of its pipeline to Regeneron Pharmaceuticals for cheap in...